Skip to main content
. 2018 Mar 6;18:61. doi: 10.1186/s12888-018-1642-x

Table 2.

Assessment schedule for the PRIME cohorts

Data collected by questionnaire Depression Alcohol use disorders Psychosis Epilepsy
Months of follow-upa 0 3/6 12 0 3 12 0 6 12 0 6 12
Demographics characteristics
Clinical Measures
 WHO Disability Assessment Schedule (WHODAS 2.0) [34]
 Patient Health Questionnaire (PHQ-9) [26]
 Alcohol Use Disorder Identification Test (AUDIT) [27]
 Short Inventory of Problems – Recent (SIP 2-R] [75, 76]
 Suicidality (Composite International Diagnostic Interview - suicidality module) [77]
 Epilepsy severity (developed by PRIME)
 Brief Psychiatric Rating Scale (BPRS-E) [30]
 Positive and Negative Syndrome Scale (PANSS) [78]
Health Service Use
 Group/community interventions (developed by PRIME)
 Mental health services received (developed by PRIME)
 Health Service use and costs (adapted from the Client Service Receipt Inventory)
Medication adherence
 Morisky Medication Adherence Scale (4-item) [79]
 Medication adherence (adapted from Care for People with Schizophrenia in India)
Social and economic measures
 Economic activity (adapted from WHODAS 2.0, added items by PRIME)
 Severe Adverse Events (developed by PRIME)
 Oslo 3-item Social Support Scale [80]
 Caregiver work burden - WHO Family Interview Schedule (Impact) [81]
 Caregiver economic activity (adapted from WHODAS 2.0, items added by PRME)
Stigma and discrimination
 Discrimination and Stigma Scale [82]
 Caregiver stigma & discrimination - WHO Family Interview Schedule (Stigma) [81]
 Human rights abuse by caregiver (developed by PRIME)

a6 months for depression in Ethiopia